期刊
BIOMEDICINES
卷 9, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines9010074
关键词
gold nanoparticles; albumin theranostic conjugates; boronated albumin conjugate; trifluorothymidine-albumin conjugate; fluorescence-based molecular imaging
资金
- Russian Science Foundation [19-74-20123]
- Russian Science Foundation [19-74-20123] Funding Source: Russian Science Foundation
This study demonstrates the development of a theranostic system by conjugating anticancer nucleotides or boron-neutron capture therapy drugs to human serum albumin and reacting with gold nanoparticles. Despite a long circulation time, the accumulation of the therapeutic conjugates in the tumor was not significant.
Multifunctional gold nanoparticles (AuNPs) may serve as a scaffold to integrate diagnostic and therapeutic functions into one theranostic system, thereby simultaneously facilitating diagnosis and therapy and monitoring therapeutic responses. Herein, albumin-AuNP theranostic agents have been obtained by conjugation of an anticancer nucleotide trifluorothymidine (TFT) or a boron-neutron capture therapy drug undecahydro-closo-dodecaborate (B12H12) to bimodal human serum albumin (HSA) followed by reacting of the albumin conjugates with AuNPs. In vitro studies have revealed a stronger cytotoxicity by the AuNPs decorated with the TFT-tagged bimodal HSA than by the boronated albumin conjugates. Despite long circulation time, lack of the significant accumulation in the tumor was observed for the AuNP theranostic conjugates. Our unique labelling strategy allows for monitoring of spatial distribution of the AuNPs theranostic in vivo in real time with high sensitivity, thus reducing the number of animals required for testing and optimizing new nanosystems as chemotherapeutic agents and boron-neutron capture therapy drug candidates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据